Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.


Celerite Slimming Tea: Recall - Undeclared Drug Ingredient

[Posted 03/28/2011]

AUDIENCE: Consumer

ISSUE: FDA laboratory analyses of the product were found to contain undeclared Sibutramine, which is used as an appetite suppressant for weight loss. The FDA has not approved the product as a drug; therefore, the safety and effectiveness of the product is unknown. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.

BACKGROUND: The product was sold and distributed nationwide via the internet at

RECOMMENDATION: Consumers are advised to return the product to the company’s address in Southampton, PA.

Healthcare professionals and patients are encouraged to report adverse events, side effects, or product quality problems related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online:
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


[03/15/2011 - Press Release - Shaping Beauty, Inc.]
[01/12/2011 - Tainted Weight Loss Products - FDA]

Related MedWatch alert:

[01/13/2011 - Celerite Slimming Capsules]

Page Last Updated: 06/02/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English